Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-17-000229
Filing Date
2017-04-04
Accepted
2017-04-04 16:42:41
Documents
1
Group Members
ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTJON M. SAKODAJOSHUA MAKOWERNEA 15 GP, LLCNEA PARTNERS 15, L.P.NEW ENTERPRISE ASSOCIATES 15, L.P.PETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A - AMEND. NO. 1 aveo-sch13da_18057.htm SC 13D/A 406496
  Complete submission text file 0001072613-17-000229.txt   408438
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617- 531-2130
AVEO PHARMACEUTICALS INC (Subject) CIK: 0001325879 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85745 | Film No.: 17738952
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
Growth Equity Opportunities IV, LLC (Filed by) CIK: 0001644965 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A